Tag: ASX: TLX
Telix to acquire ITM in US$1.65 billion radiopharmaceutical deal
Telix Pharmaceuticals has announced plans to acquire German radiopharmaceutical company ITM Isotope Technologies Munich SE for US$1.65 billion, in a transaction the company says will expand its capabilities across the radiopharmaceutical value chain.
Telix ventures into advanced isotope production with ARTMS acquisition
Telix Pharmaceuticals Limited has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc, its advanced cyclotron-based isotope production platform, manufacturing plant, and stockpile of ultra-pure rare metals required for consumable target production.
ASX-listed Telix Pharmaceuticals unveils potential plan for US listing
Melbourne-based biopharmaceutical giant Telix Pharmaceuticals announced today its plans for an initial public offering in the United States and listing on the Nasdaq Global...
Australian pharma firm Telix opens $21m radiopharmaceutical production facility in Belgium
ASX-listed Telix Pharmaceuticals has recently opened Telix Manufacturing Solutions, the company's radiopharmaceutical production facility in Belgium, serving as the primary manufacturing site for radioisotopes and commercial and clinical products for patients in the Europe Middle East and Africa (EMEA) region.
Featured Article
Xometry CEO Sanjeev Singh Sahni on how AI and digital networks are reshaping manufacturing supply chains
Australian manufacturers have long competed against distance. In an exclusive interview with Australian Manufacturing, Xometry CEO Sanjeev Singh Sahni discusses how AI can help manufacturers access more production capacity and simplify traditionally email-driven supply chains.
